Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
AbbVie’s monopoly has hiked prices – it’s time to burst the bubble and get prices back down to earth. Activists...
An important step towards affordable TAF in Ukraine
Gilead adds TAF, a drug used in HIV and Hepatitis B treatment, to the Medicines Patent Pool for Ukraine. It...
Ukraine: HIV patients appeal against deadly patent monopoly
Unmerited patents protecting profit not patients – protesting & appealing the decisions so far. 50% of Ukraine’s budget for HIV...
Patients and Ministers discuss access to essential medicines in Ukraine
Working together to reform patent law in Ukraine – and new Working Group is founded. Last month (21 April) our...
#TreatPeopleRight – Highlights from the ITPC Annual Review
Campaign activity contributing to combined savings of US$700 million for health budgets is among ITPC’s 2016 highlights The mission of...
Advocating for an improved patent applications process in Ukraine
The decision to grant or refuse a patent has an impact on the price of essential medicines – and huge...
All-Ukrainian Network of PLHIV continues to struggle for affordable LPV/r
Network of people living with HIV submits second opposition to patent on essential HIV drug in Ukraine On 30 January...
Patent on HIV and Hepatitis drug TAF challenged in Ukraine
On 28 December 2016, the All-Ukrainian Network of People Living with HIV/AIDS submitted a patent invalidation claim against Gilead patent...
Debating patent law and access to medicines in Ukraine
Last month (9 December 2016), the All-Ukrainian Network of People Living with HIV/AIDS held a roundtable meeting on ‘Patent Law...
Price of HIV Drug Atripla Set to Drop
Almost 3000 more people living with HIV set to get life-saving treatment in Ukraine.